综合一区欧美国产,99国产麻豆免费精品,九九精品黄色录像,亚洲激情青青草,久久亚洲熟妇熟,中文字幕av在线播放,国产一区二区卡,九九久久国产精品,久久精品视频免费

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

AstraZeneca announces medical AI cooperation with Chinese companies

By ZHENG YIRAN | chinadaily.com.cn | Updated: 2020-07-02 16:25
Share
Share - WeChat
The AstraZeneca logo. [Photo/astrazeneca.com.cn]

During the upcoming 2020 World Artificial Intelligence Conference in Shanghai, United Kingdom-based pharmaceutical company AstraZeneca said it will launch 10 major application scenarios integrating AI with healthcare, further boosting its cooperation in innovation with Chinese companies, said a senior official.

Leon Wang, executive vice-president and China president at AstraZeneca, said for the 2020 WAIC, which will be held between July 9 and 11, the company will reveal the latest applications of AI in the healthcare sector, covering scenarios including pharmaceutical research and development, drug production, diagnosis and treatment, and the company is open to cooperation opportunities with Chinese firms.

"Through the cooperation, with the help of advanced technologies such as machine vision, prediction algorithms and natural language understanding, we hope to explore deeply into the processes including screening, diagnosis, treatment and patient follow-up. In this way, we are able to promote the application of AI in various diseases, fully increase work efficiency and benefit Chinese patients better," he said.

It is estimated the company may announce the cooperation and innovative achievements by the WAIC next year, he added.

To foster innovative cooperation with Chinese companies, with the help of the local government, last year AstraZeneca built the Wuxi International Life Science Innovation Campus in Wuxi, Jiangsu province. According to the company, it plans to launch more life science innovation campuses in more cities in the future, including Beijing, Shanghai, Guangzhou, Chengdu and Hangzhou.

Working with China International Capital Corp Ltd, AstraZeneca launched a medical fund worth $1 billion. The fund was raised to invest in medical innovation in China.

Currently, the first phase of fundraising is completed. It is estimated the fund will start to use this year to assist Chinese innovative enterprises, Wang said.

CICC said AI is changing the world, and has become an inevitable trend. The company will focus on the latest application of AI and promote the exploration and landing of applications.

Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
阳城县| 利辛县| 红原县| 保山市| 济阳县| 定南县| 满洲里市| 婺源县| 博爱县| 梅州市| 焦作市| 虞城县| 阿拉尔市| 上栗县| 施甸县| 逊克县| 永平县| 新绛县| 长治县| 健康| 北碚区| 平凉市| 翼城县| 壶关县| 旺苍县| 韩城市| 张家口市| 集贤县| 弥勒县| 缙云县| 乌苏市| 新巴尔虎左旗| 凌源市| 兰西县| 宝丰县| 新田县| 浮梁县| 余庆县| 河北区| 东辽县| 齐河县|